182 related articles for article (PubMed ID: 30142759)
21. Speckled antinuclear antibodies in keratinocytes--what does it mean?
Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
[TBL] [Abstract][Full Text] [Related]
22. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
23. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
Irure-Ventura J; Rodríguez C; Vergara-Prieto E; Vargas ML; Quirant B; Jurado A; Fernández-Pereira L; Martínez-Cáceres E; San José M; López-Hoyos M;
Rheumatology (Oxford); 2021 Aug; 60(8):3904-3912. PubMed ID: 33437990
[TBL] [Abstract][Full Text] [Related]
24. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.
Nardi N; Brito-Zerón P; Ramos-Casals M; Aguiló S; Cervera R; Ingelmo M; Font J
Clin Rheumatol; 2006 May; 25(3):341-6. PubMed ID: 16249826
[TBL] [Abstract][Full Text] [Related]
25. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
26. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
[TBL] [Abstract][Full Text] [Related]
27. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
28. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
29. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
30. Significance of the immunofluorescence staining patterns and titres of the antinuclear antibody test in paediatric rheumatology setting.
Baba Ö; Kısaoğlu H; Kalyoncu M
Turk J Med Sci; 2023 Feb; 53(1):193-198. PubMed ID: 36945955
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
[TBL] [Abstract][Full Text] [Related]
32. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cells transfected with human 60 kDa Ro/SS-A.
Pollock W; Toh BH
J Clin Pathol; 1999 Sep; 52(9):684-7. PubMed ID: 10655991
[TBL] [Abstract][Full Text] [Related]
33. [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].
Mierau R
Z Rheumatol; 2016 May; 75(4):372-80. PubMed ID: 26820723
[TBL] [Abstract][Full Text] [Related]
34. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
[TBL] [Abstract][Full Text] [Related]
35. Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience.
Infantino M; Pregnolato F; Bentow C; Mahler M; Benucci M; Li Gobbi F; Damiani A; Grossi V; Franceschini F; Bodio C; Borghi MO; Manfredi M
Clin Chem Lab Med; 2019 Oct; 57(11):1764-1769. PubMed ID: 31318689
[TBL] [Abstract][Full Text] [Related]
36. Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.
Tsirves GK; Voulgari PV; Pelechas E; Asimakopoulos AD; Drosos AA
Eur Arch Otorhinolaryngol; 2019 Sep; 276(9):2419-2426. PubMed ID: 31175453
[TBL] [Abstract][Full Text] [Related]
37. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
38. Range of antinuclear antibodies in "healthy" individuals.
Tan EM; Feltkamp TE; Smolen JS; Butcher B; Dawkins R; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; McDougal JS; Rothfield NF; Smeenk RJ; Takasaki Y; Wiik A; Wilson MR; Koziol JA
Arthritis Rheum; 1997 Sep; 40(9):1601-11. PubMed ID: 9324014
[TBL] [Abstract][Full Text] [Related]
39. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
